Urinary System pp 317-322 | Cite as

Carcinogenesis, Urinary Tract, Rat

  • Nobuyuki Ito
  • Shoji Fukushima
Part of the Monographs on Pathology of Laboratory Animals book series (LABORATORY)


Animal models are very useful for studying the pathogenesis of human disease. Experimental chemical carcinogenesis in the urinary tract and in particular the urinary bladder has advanced the development of animal models for human cancer. This paper describes carcinogenesis in the urinary tract with special attention to experimental urinary bladder carcinogenesis.


Urinary Bladder Transitional Cell Carcinoma Histiocytic Sarcoma Urinary Bladder Carcinoma Urinary Bladder Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Cohen SM, Jacobs JB, Arai M, Johansson S, Friedell GH (1976) Early lesions in experimental bladder cancer: experimental design and light microscopic findings. Cancer Res 36: 2508–2511PubMedGoogle Scholar
  2. Cohen SM, Arai M, Jacobs JB, Friedell GH (1979) Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cancer Res 39: 1207–1217PubMedGoogle Scholar
  3. Croft WA, Bryan GT (1973) Production of urinary bladder carcinomas in male hamsters by N-[4-(5-nitro-2furyl)-2-thiazolyllformamide’ N-[4-(50nitro-2-furyl)-2thiazolyll acetamide, or formic acid 2-[4-(5-nitro-2furyl)-2-thiazolyl] hydrazide. JNCI 51: 941–949PubMedGoogle Scholar
  4. Druckrey H, Preussman R, Ivankovic S, Schmidt CH, Mennel HD, Stahl KW (1964) Selektive Erzeugung von Blasenkrebs an Ratten durch Dibutyl-und N-Butyl-N-butanol(4)-notrosam(n. Z Krebsforsch 66: 280–290PubMedCrossRefGoogle Scholar
  5. Ertürk E, Cohen SM, Price JM, Bryan GT (1969) Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-[4-(5-nitro-2-furyl)-2-thiazolyllformamide. Cancer Res 29: 2219–2228PubMedGoogle Scholar
  6. Fukushima S, Murasaki G, Hirose M, Nakanishi K, Hasegawa R, Ito N (1982) Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats. Acta Pathol Jpn 32: 242–250Google Scholar
  7. Fukushima S, Imaida K, Sakata T, Okamura T, Shibata M, Ito N (1983) Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. Cancer Res 43: 4454–4457PubMedGoogle Scholar
  8. Fukushima S, Kurata Y, Shibata M, Ikawa E, Ito N (1984) Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl)-nitrosamine. Cancer Lett 23: 29–37PubMedCrossRefGoogle Scholar
  9. Hashimoto Y, Suzuki E, Okada M (1972) Induction of urinary bladder tumors in ACI-N rats by butyl(3-carboxypropyl)nitrosoamine, a major urinary metabolite of butyl(4-hydroxybutyl)nitrosoamine. Gann 63: 637–638PubMedGoogle Scholar
  10. Hicks RM, Wakefield JS-J (1972) Rapide induction of bladder cancer in rats with N-methyl-N-nitrosourea. I. Histology. Chem Biol Interact 5: 139–152PubMedCrossRefGoogle Scholar
  11. Hicks RM, Wakefield JS-J, Chowaniec J (1975) Evaluation of a new model to detect bladder carcinogens or co-carcinogens; results obtained with saccharin, cyclamate and cyclophosphamide. Chem Biol Interact 11: 225–233PubMedCrossRefGoogle Scholar
  12. Hirose M, Fukushima S, Hananouchi M, Shirai T, Ogiso T, Takahashi M, Ito N (1976) Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. Gann 67: 175–189PubMedGoogle Scholar
  13. Imaida K, Fukushima S, Shirai T, Ohtani M, Nakanishi K, Ito N (1983) Promotin activities of butylated hydroxyanisole and butylated bydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats. Carcinogenesis 4: 895–899PubMedCrossRefGoogle Scholar
  14. Ito N, Hiasa Y, Tamai A, Okajima E, Kitamura H (1969) Histogenesis of urinary bladder tumors induced by N-butyl- N-(4-hydroxybutyl)nitrosamine in rats. Gann 60: 401–410PubMedGoogle Scholar
  15. Ito N, Makiura S, Yokota Y, Kamamoto Y, Hiasa Y, Sugihara S (1971) Effect of unilateral ureter ligation on development of tumors in the urinary system of rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine. Gann 62: 359–365PubMedGoogle Scholar
  16. Ito N, Matayoshi K, Arai M, Yoshioka Y, Kamamoto Y, Makiura S, Sugihara S (1973) Effect of various factors on induction of urinary bladder tumors in animals by N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 64: 151–159PubMedGoogle Scholar
  17. Nakanishi K, Hagiwara A, Shibata M, Imaida K, Tatematsu M, Ito N (1980) Dose-response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. JNCI 65: 1005–1010PubMedGoogle Scholar
  18. Okada M, Suzuki EM, Mochizuki M (1976) Possible important role of urinary N-methyl-N-(3-carboxypropyl)nitrosamine in the induction of bladder tumors in rats by N-methyl-N-dodecylnitrosamine. Gann 67: 771–772PubMedGoogle Scholar
  19. Okajima E, Hiramatsu T, Hirao K, Ijuin M, Hirao Y, Ba-baya K, Ikuma S, Ohara S, Shiomi T, Hijioka T, Ohishi H (1981) Urinary bladder tumors induced by N-butyl-N(4-hydroxybutyl)nitrosamine in dogs. Cancer Res 41: 1958–1966PubMedGoogle Scholar
  20. Oyasu R, Hirao Y, Izumi K (1981) Enhancement by urine of urinary bladder carcinogenesis. Cancer Res 41: 478–481PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • Nobuyuki Ito
  • Shoji Fukushima

There are no affiliations available

Personalised recommendations